CROI 2014: Advances in antiretroviral therapy

Barbara S. Taylor, Noga Shalev, Timothy J. Wilkin

Producción científica: Conference articlerevisión exhaustiva

1 Cita (Scopus)


The 2014 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted important advances in antiretroviral therapy, with an emphasis on HIV eradication strategies. Follow-up information about the Mississippi baby who remains free of HIV infection off antiretroviral therapy was presented, and a second baby and 1 adult may also have been cured with very early initiation of antiretroviral therapy. The HIV care cascade was again a major focus of the conference. Investigators from around the world presented data on the implementation, and limitations, of the care cascade paradigm. Scale-up of antiretroviral therapy continues and a number of presentations featured optimal ways to measure the impact of these efforts by applying lessons from implementation science and health care economics. Encouraging results from expanded prevention of mother-to-child transmission programs, especially Option B+, were highlighted. Extensive data on transmitted (primary) drug resistance in the United States and Europe were presented.

Idioma originalEnglish (US)
Páginas (desde-hasta)616-631
Número de páginas16
PublicaciónTopics in Antiviral Medicine
EstadoPublished - 2014
EventoAnnual Conference on Retroviruses and Opportunistic Infections, CROI 2014 - Boston, MA, United States
Duración: mar 3 2014mar 6 2014

ASJC Scopus subject areas

  • General Medicine


Profundice en los temas de investigación de 'CROI 2014: Advances in antiretroviral therapy'. En conjunto forman una huella única.

Citar esto